Healx Rare Treatment Accelerator
Healx
Award
Up to ~$1M in-kind AI drug-discovery resources per project
Deadline
Status unconfirmed — call page dates from 2020
Award type
In-kind support
Focus
Preclinical & therapeutics
AI-driven drug-repurposing partnerships with rare-disease patient groups, academics, and early-stage biotechs, aiming to move repurposed candidates toward the clinic in roughly 24 months. $20M is committed; prior partners include FAST/Angelman and FARA.
Why it's in this index
BSF would apply as the patient-group partner rather than an individual researcher. The 2026 call cadence could not be verified — current status is posted at healx.ai.
Who can apply
Rare-disease patient groups and foundations; expanded to academic groups and biotechs under RTA 2.0.
How to apply
Register interest via healx.ai.
Links & downloads
Related programs
Permalink
/grants/healx-rare-treatment-accelerator/
Last updated August 28, 2026 · Suggest an update to this entry